{
    "uniprot_canonical_ac": "A4QPC6-1", 
    "publication_count": 2, 
    "reported_interactions": 0, 
    "record_type": "protein", 
    "predicted_glycosites": 2, 
    "protein_names_refseq": "butyrophilin 2; butyrophilin subfamily 2 member A2 isoform 1 precursor; butyrophilin subfamily 2 member A2 isoform 2 precursor", 
    "refseq_ac": "NP_001276544.1", 
    "reported_n_glycosites": 0, 
    "refseq_name": "butyrophilin subfamily 2 member A2 isoform 1 precursor", 
    "record_id": "A4QPC6-1", 
    "protein_names_uniprotkb": "Butyrophilin subfamily 2 member A2; Btn2a2 protein; Butyrophilin subfamily 2 member A2", 
    "pathway": " (mmu:238555); Butyrophilin (BTN) family interactions (R-MMU-8851680)", 
    "function": "Btn2a2(-/-) mice exhibited enhanced effector CD4(+) and CD8(+) T cell responses, impaired CD4(+) regulatory T cell induction, potentiated antitumor responses, and exacerbated experimental autoimmune encephalomyelitis., [RefSeq]; Btn2a2(-/-) mice exhibited enhanced effector CD4(+) and CD8(+) T cell responses, impaired CD4(+) regulatory T cell induction, potentiated antitumor responses, and exacerbated experimental autoimmune encephalomyelitis., [RefSeq]; Inhibits the proliferation of CD4 and CD8 T-cells activated by anti-CD3 antibodies, T-cell metabolism and IL2 and IFNG secretion., [UniProtKB]; These data are consistent with a coinhibitory role for mouse Butyrophilins, [RefSeq]; These data are consistent with a coinhibitory role for mouse Butyrophilins, [RefSeq]", 
    "protein_name": "Butyrophilin subfamily 2 member A2", 
    "reported_mutagensis": 0, 
    "reported_phosphosites": 0, 
    "reported_o_glycosites_with_glycan": 0, 
    "tax_id": 10090, 
    "organism": "Mus musculus", 
    "disease": "", 
    "reported_glycation": 0, 
    "reported_snv": 0, 
    "mass": 58455.0, 
    "gene_names_uniprotkb": "Btn2a2", 
    "reported_n_glycosites_with_glycan": 0, 
    "reported_o_glycosites": 0, 
    "gene_names_refseq": "Btn2; D030063K05; Btn2a2", 
    "gene_name": "Btn2a2"
}